Psychedelic News Alerts
@psil_ai
Followers
38
Following
1
Statuses
508
Joined August 2023
"#Cybin launches strategic clinical site partnerships for PARADIGM Phase 3 program, anticipates enrollment of 550 patients. Cash at $136.3M. #pharmaceuticals" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF
0
0
0
"CYBN reports strategic clinical site partnerships for PARADIGM Phase 3 program, advancing CYB003 for MDD treatment. Cash at $136.3M. New ATM program for up to $100M in equity. #biotech" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF
0
0
0
"HC Wainwright & Co. Stands by Buy Rating for Cybin, L... - See Why!"
1
0
0
"#Cybin announces strategic clinical site partnerships to accelerate Phase 3 program for CYB003 in MDD, with anticipated enrollment of 550 patients. Cash totaled C$136.3 million as of Dec. 2024." #biotech #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF
1
0
3
"#Cybin launches strategic clinical site partnerships to accelerate PARADIGM Phase 3 program for MDD treatment. Cash at $136.3M. #Neuropsychiatry" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF
0
0
2
Canaccord Genuity Sticks with Buy Rating on Cybin, Low...
1
0
0
#Cybin accelerates #PARADIGM program for #MDD treatment with strategic site partnerships & upcoming milestones for #CYB003 & #CYB004. Cash balance of C$136.3M as of Dec. 31, 2024. #clinicaltrials #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF
0
0
0
"Check out Cybin Inc's Q3 Financial Report and Clinical Program Advancements on NYSE American and NEO!"
1
0
1
"#CybinInc reports strategic clinical site partnerships to accelerate Phase 3 program for CYB003 in MDD, with anticipated enrollment of 550 patients. Cash totaled C$136.3M as of Dec. 31, 2024." #biotech #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF
0
0
2
"Cybin's Q3 FY2025 Financial Results and Business Highlights - See the Latest Update!"
1
0
0
"Cybin's Q3 Fiscal Year 2025 Financial Results and Business Highlights: A Look Inside"
1
0
0
"Cybin's Q3 Fiscal Year 2025 Financial Results and Business Highlights"
1
0
0
"#Cybin launches strategic clinical site partnerships to accelerate PARADIGM Phase 3 program for MDD treatment. Cash totaled C$136.3M as of Dec 31, 2024. New ATM program for up to US$100M. #biotech" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF
2
0
4
Cybin Inc. reports Q3 financial results and key updates, including launch of clinical site partnerships for CYB003 Phase 3 program in MDD and initiation of Phase 2 study for CYB004 in GAD. #biotech #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF
0
0
1
#Cybin announces strategic partnership with Segal Trials for Phase 3 program evaluating CYB003 for MDD treatment. Phase 2 data shows promising results. #biotech #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF
0
0
0
#Cybin announces strategic partnership with Segal Trials for Phase 3 program evaluating CYB003 for MDD treatment. Phase 2 data shows promising results. #biotech #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF
0
0
0
"Unlocking Mental Health: The Growing Psychedelic Drugs Market"
1
0
0
#Cybin announces strategic partnership with Segal Trials for Phase 3 program evaluating CYB003 for MDD treatment. Phase 2 data shows promising results. #biotech #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF
0
0
1
#Cybin announces strategic partnership with Segal Trials for Phase 3 program evaluating CYB003 for MDD treatment. Phase 2 data shows promising results. #biotech #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF
0
0
0